Kalaris Therapeutics, Inc. · NASDAQ:KLRS

Kalaris Therapeutics, Inc. financial statements

Kalaris Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue0000165.0K1.14M
Cost of revenue13.0K1.12M73.0K
Gross profit-13.0K-1.12M-73.0K
Research and development30.8M45.0M133.1M118.9M120.7M49.7M16.2M1.70M
Selling, general and administrative15.4M6.69M1.76M2.24M
Operating income-46.2M-51.7M-199.9M-171.2M-169.8M-71.3M-26.7M-3.60M
Depreciation and amortization13.0K0398.0K723.0K189.0K73.0K19.0K
EBITDA-46.1M-51.7M-199.5M-170.5M-169.6M-71.2M-26.7M
Interest expense1.44M2.70M687.0K235.0K
Income before tax-43.4M-69.2M-190.5M-169.0M-171.0M-69.8M-23.8M-2.43M
Income tax00-126.0K-265.0K1.01M
Net income-43.4M-69.2M-190.4M-168.7M-172.0M-69.8M-23.8M-2.43M
Earnings per share, basic-2.85-51.77-42.09-2.20-2.74-2.59-18.54-0.86
Earnings per share, diluted-2.85-51.77-42.09-2.20-2.74-2.59-18.54

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents98.1M1.64M90.1M106.1M201.7M122.7M61.1M25.0M
Short-term investments19.9M093.8M127.7M46.5M233.7M65.0M
Receivables50.0K450.0K560.0K302.0K
Current assets118.8M2.61M187.6M243.1M253.3M361.3M127.3M25.3M
Property, plant and equipment930.0K1.55M812.0K350.0K
Total assets121.7M6.16M190.8M277.1M286.6M370.8M139.4M25.3M
Accounts payable1.28M1.56M6.76M3.00M8.36M963.0K630.0K153.0K
Current liabilities9.71M24.7M28.4M24.3M37.9M12.3M9.11M3.74M
Long-term debt3.25M
Total debt1.45M3.25M30.1M8.69M11.8M
Total liabilities42.9M56.8M45.0M52.6M61.3M17.8M17.8M3.74M
Shareholders' equity78.8M-96.6M-45.0M224.5M225.3M353.1M-51.5M21.6M
Shares outstanding22.9M1.36M4.96M93.1M63.6M61.9M2.10M2.83M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-38.4M-20.7M-124.5M-142.1M-106.3M-60.8M-20.2M1.94M
Capital spending-200.0K000-26.0K-235.0K-339.0K0
Free cash flow-38.6M-67.7M-14.1M-9.78M-106.3M-61.0M-20.5M1.94M
Cash from investing-19.7M95.0M38.0M-80.5M186.0M-169.5M-64.6M
Cash from financing155.0M19.1M70.5M127.0M232.0K292.0M120.9M22.9M
Share buybacks-10.0M
Change in cash96.9M-1.53M-16.0M-95.6M79.9M61.6M36.1M25.0M